Nurmohamed, Michael T.
Article History
First Online: 30 April 2019
Competing interests
: M.T.N. declares he has received research support and lecture fees from Abbvie, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sanofi and UCB; and has been on the advisory boards for Abbvie, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Eli Lilly, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sanofi and UCB.